TRK-ing the Path to NTRK Fusions for Tumor Agnostic Precision Medicine
TRK-ing the Path to NTRK Fusions for Tumor Agnostic Precision Medicine
Related Articles
Pier pressure: more than 1,000 sea lions assemble at San Francisco dockside
Tourists delighted as pinnipeds congregate at city’s Pier 39, apparently attracted by feast of anchovies
Senior homes refuse to pick up fallen residents, dial 911. ‘Why are they calling us?’
Cities are frustrated by 911 calls from senior facilities to help residents off the floor or toilet. Some are now charging fees, but facilities keep…
Science Magazine – Cuts to high-profile NIH efforts leave researchers reeling
When the U.S. government’s spending bills for this fiscal year were belatedly finalized in March, the U.S. National Institutes of Health (NIH) largely escaped the…
Stevie Ray Vaughan Acoustic Guitar Solo- RARE Video Footage
Stevie Ray Vaughan Acoustic Guitar Solo- RARE Video Footage
My PI yelled at me and I’m devastated. What do I do?
Nature – It can be hard when junior scientists feel unsupported. Nature asked three scientists for their advice on how to respond.
3D genomic mapping reveals multifocality of human pancreatic precancers
Nature – Quantitative multimodal 3D reconstruction of human pancreatic tissue at single-cell resolution reveals a high burden of multifocal, genetically heterogeneous pancreatic intraepithelial…
New study challenges long-held assumption about cancer
Cancers can’t develop without genetic mutations — or can they? Key Takeaways • Cancer cells develop from genetic mutations in DNA. • However, a new…
Normal or improved cardiovascular risk factors in IGF-I-deficient adults with growth hormone receptor deficiency
Guevara-Aguirre et al. evaluated the cardiovascular disease risk factors in individuals with Laron syndrome and their relatives to identify the effects of decreased growth hormone signaling…
Tribulations and future opportunities for artificial intelligence in precision medicine – Journal of Translational Medicine
Upon a diagnosis, the clinical team faces two main questions: what treatment, and at what dose? Clinical trials’ results provide the basis for guidance and…
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Nature Communications – CAR T cell immunotherapy for paediatric solid and brain tumours is constrained by the availability of targetable antigens. Here, the authors investigate…